Extension Safety and Immunogenicity Study of GPNV-001

NCT05982314 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: Gamma-PN3
BIOLOGICAL: Pneumovax-23
BIOLOGICAL: Prevenar-13
BIOLOGICAL: Placebo

Sponsor

GPN Vaccines